• Info
  • Insider Ownership

Insider Trading & Ownership of AARON KANTOFF

Location
Wayne, PA
Summary
The estimated net worth of AARON KANTOFF is at least $557,970 dollars as of 28 Oct 2025. AARON KANTOFF is the Director of Centessa Pharmaceuticals plc and owns shares of Centessa Pharmaceuticals plc (CNTA) stock worth about $477.6K. AARON KANTOFF is the Director of Avalo Therapeutics, Inc. and owns shares of Avalo Therapeutics, Inc. (AVTX) stock worth about $80.4K.
Signature
/s/ Brad Middlekauff, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when AARON KANTOFF files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of AARON KANTOFF

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CNTA Centessa Pharmaceuticals plc Director $477,600 18 Nov 2021
AVTX Avalo Therapeutics, Inc. Director $80,370 17 Jun 2025
TRML Tourmaline Bio, Inc. Director $0 28 Oct 2025

Insider Transactions Reported by AARON KANTOFF:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.